Health Care & Life Sciences » Biotechnology | Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
255.56 M
Public Float
226.28 M
Vertex Pharmaceuticals Inc.
Stock Exchange Mexican Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
255.56 M
Public Float
226.28 M
Vertex Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.3
Market Cap
$45.68 B
Shares Outstanding
256.12 M
Public Float
255.16 M

Profile

Address
50 Northern Avenue
Boston Massachusetts 02210
United States
Employees -
Website http://www.vrtx.com
Updated 07/08/2019
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S.

Financials

View All
Created with Highcharts 5.0.14Vertex Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Millions.4454457387385565561121122632632 0962 09620132014201520162017201805001000150020002500
Created with Highcharts 5.0.14Vertex Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Millions.1 2121 2125805801 0321 0321 7021 7022 4892 4893 0493 04920132014201520162017201801k2k3k4k

Jeffrey M. Leiden
Chairman, President & Chief Executive Officer
Alan M. Garber
Independent Director